retatrutide dosing regimen phase 2 trial Dosage: Week-by-Week Chart 2026 Retatrutide Dosing Guide for Researchers

Individual responses vary considerably, with some patients achieving dramatic results while others experience more modest weight reduction

In contrast, patients who switched to phentermine after losing at least 20 pounds while on a GLP-1 receptor agonist were more likely to regain weight 1 year after discontinuing the GLP-1 medication, with more than half regaining at least some of their weight

has done educational work for Eli Lilly and Novo Nordisk

There is enormous exuberance about starting GLP-1 drugs, but not nearly enough attention to what happens when people stop, said senior author Ziyad Al-Aly, MD, a WashU Medicine clinical epidemiologist and chief of the Research and Development Service at the VA Saint Louis Health Care System

Interrelationship of dipeptidyl peptidase IV (DPP4) with the development of diabetes, dyslipidaemia and nephropathy: a streptozotocin-induced model using wild-type and DPP4-deficient rats